Lingering CAR T cells may be the cause of serious gut complication after myeloma therapy
Patients with multiple myeloma who developed a serious gastrointestinal side effect after treatment with chimeric antigen receptor (CAR) T cell therapy had significantly more CAR T cells persisting in their bloodstream, according ...
10 hours ago
0
4








